OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
First-Line Biologic Therapy and Obesity in Moderate-to-Severe Psoriasis: Results from the Prospective Multicenter Cohort Psobioteq
Florence Assan, Florence Tubach, Hugo Arlégui, et al.
Dermatology (2021) Vol. 237, Iss. 3, pp. 338-346
Closed Access | Times Cited: 11
Florence Assan, Florence Tubach, Hugo Arlégui, et al.
Dermatology (2021) Vol. 237, Iss. 3, pp. 338-346
Closed Access | Times Cited: 11
Showing 11 citing articles:
Tildrakizumab: the value of a personalized and flexible approach for treating moderate-to-severe plaque psoriasis in patients with high body weight or high disease burden
Paolo Dapavo, Martina Burlando, Claudio Guarneri, et al.
Expert Opinion on Biological Therapy (2024) Vol. 24, Iss. 3, pp. 133-138
Open Access | Times Cited: 4
Paolo Dapavo, Martina Burlando, Claudio Guarneri, et al.
Expert Opinion on Biological Therapy (2024) Vol. 24, Iss. 3, pp. 133-138
Open Access | Times Cited: 4
Palmoplantar pustulosis and acrodermatitis continua of Hallopeau: demographic and clinical comparative study in a large multicentre cohort
Florence Assan, B. Husson, S. Hegazy, et al.
Journal of the European Academy of Dermatology and Venereology (2022) Vol. 36, Iss. 9, pp. 1578-1583
Open Access | Times Cited: 15
Florence Assan, B. Husson, S. Hegazy, et al.
Journal of the European Academy of Dermatology and Venereology (2022) Vol. 36, Iss. 9, pp. 1578-1583
Open Access | Times Cited: 15
Prevalence of metabolic syndrome and chronic inflammation in psoriasis before and after biologic therapy: a prospective study
Teodora-Larisa Timiș, Lehel Beni, Ioan Alexandru Florian, et al.
Medicine and Pharmacy Reports (2023) Vol. 96, Iss. 4, pp. 368-383
Open Access | Times Cited: 8
Teodora-Larisa Timiș, Lehel Beni, Ioan Alexandru Florian, et al.
Medicine and Pharmacy Reports (2023) Vol. 96, Iss. 4, pp. 368-383
Open Access | Times Cited: 8
The Effectiveness of Guselkumab by BMI Category Among Patients with Moderate-to-Severe Plaque Psoriasis in the CorEvitas Psoriasis Registry
April W. Armstrong, Timothy Fitzgerald, Robert R. McLean, et al.
Advances in Therapy (2023) Vol. 40, Iss. 5, pp. 2493-2508
Closed Access | Times Cited: 4
April W. Armstrong, Timothy Fitzgerald, Robert R. McLean, et al.
Advances in Therapy (2023) Vol. 40, Iss. 5, pp. 2493-2508
Closed Access | Times Cited: 4
Improvement of psoriasis vulgaris in a patient with obesity after bariatric and metabolic surgery: A case letter
Shinji Mitsuyama, Tetsuya Higuchi, Taiki Nabekura, et al.
The Journal of Dermatology (2024) Vol. 51, Iss. 12
Closed Access
Shinji Mitsuyama, Tetsuya Higuchi, Taiki Nabekura, et al.
The Journal of Dermatology (2024) Vol. 51, Iss. 12
Closed Access
Ixekizumab trough concentrations in psoriasis: Paving the way towards personalised therapy: A cohort study
Lisa Schots, Rani Soenen, Debby Thomas, et al.
JEADV Clinical Practice (2024)
Open Access
Lisa Schots, Rani Soenen, Debby Thomas, et al.
JEADV Clinical Practice (2024)
Open Access
Prospective Real-Life Multicenter Study of Tildrakizumab 200 mg for Moderate-to-Severe Psoriasis: Who Is the Ideal Patient?
Eugenia Veronica Di Brizzi, Stefano Caccavale, Roberta Di Caprio, et al.
Dermatology Practical & Conceptual (2024) Vol. 14, Iss. 4, pp. e2024284-e2024284
Closed Access
Eugenia Veronica Di Brizzi, Stefano Caccavale, Roberta Di Caprio, et al.
Dermatology Practical & Conceptual (2024) Vol. 14, Iss. 4, pp. e2024284-e2024284
Closed Access
Acrodermatitis continua of hallopeau: aggravating factors and treatment outcomes of 96 patients
Liyan Yuan, Xiaoling Yu, Yanqiang Shi, et al.
Journal of Dermatological Treatment (2024) Vol. 35, Iss. 1
Open Access
Liyan Yuan, Xiaoling Yu, Yanqiang Shi, et al.
Journal of Dermatological Treatment (2024) Vol. 35, Iss. 1
Open Access
The Association between Obesity and Efficacy of Psoriasis Therapies: An Expert Consensus Panel
Joshua Burshtein, April W. Armstrong, MAY J. CHOW, et al.
Journal of the American Academy of Dermatology (2024)
Closed Access
Joshua Burshtein, April W. Armstrong, MAY J. CHOW, et al.
Journal of the American Academy of Dermatology (2024)
Closed Access
Impact of the first wave of the COVID-19 pandemic on the treatment of psoriasis with systemic therapies in France: Results from the PSOBIOTEQ cohort
Hugo Arlégui, E. Mahé, M.‐A. Richard, et al.
Annales de Dermatologie et de Vénéréologie (2023) Vol. 150, Iss. 2, pp. 101-108
Open Access | Times Cited: 1
Hugo Arlégui, E. Mahé, M.‐A. Richard, et al.
Annales de Dermatologie et de Vénéréologie (2023) Vol. 150, Iss. 2, pp. 101-108
Open Access | Times Cited: 1
Weighing in on weight‐based secukinumab dosing for psoriasis
Deepak Balak, Jo Lambert
British Journal of Dermatology (2022) Vol. 187, Iss. 1, pp. 10-11
Closed Access | Times Cited: 1
Deepak Balak, Jo Lambert
British Journal of Dermatology (2022) Vol. 187, Iss. 1, pp. 10-11
Closed Access | Times Cited: 1
